Mustang Bio, Inc.

NasdaqCM:MBIO Stock Report

Market Cap: US$3.8m

Mustang Bio Management

Management criteria checks 4/4

Mustang Bio's CEO is Manny Litchman, appointed in Apr 2017, has a tenure of 8.08 years. total yearly compensation is $498.04K, comprised of 97.5% salary and 2.5% bonuses, including company stock and options. directly owns 0.049% of the company’s shares, worth $1.90K. The average tenure of the management team and the board of directors is 5.2 years and 8.1 years respectively.

Key information

Manny Litchman

Chief executive officer

US$498.0k

Total compensation

CEO salary percentage97.48%
CEO tenure8.1yrs
CEO ownership0.05%
Management average tenure5.2yrs
Board average tenure8.1yrs

Recent management updates

Recent updates

Mustang Bio: This Horse May Gallop Still

Sep 23

Is Mustang Bio, Inc. (NASDAQ:MBIO) Trading At A 46% Discount?

Aug 09
Is Mustang Bio, Inc. (NASDAQ:MBIO) Trading At A 46% Discount?

Mustang Bio: The Market Is Missing This Opportunity

May 03

Will Mustang Bio (NASDAQ:MBIO) Spend Its Cash Wisely?

Dec 29
Will Mustang Bio (NASDAQ:MBIO) Spend Its Cash Wisely?

Mustang Bio: Remains Underfollowed Despite Moving Closer To Pivotal Studies

Sep 14

CEO Compensation Analysis

How has Manny Litchman's remuneration changed compared to Mustang Bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024US$498kUS$486k

-US$16m

Sep 30 2024n/an/a

-US$23m

Jun 30 2024n/an/a

-US$32m

Mar 31 2024n/an/a

-US$40m

Dec 31 2023US$514kUS$481k

-US$52m

Sep 30 2023n/an/a

-US$63m

Jun 30 2023n/an/a

-US$72m

Mar 31 2023n/an/a

-US$74m

Dec 31 2022US$636kUS$448k

-US$78m

Sep 30 2022n/an/a

-US$78m

Jun 30 2022n/an/a

-US$76m

Mar 31 2022n/an/a

-US$71m

Dec 31 2021US$885kUS$450k

-US$66m

Sep 30 2021n/an/a

-US$67m

Jun 30 2021n/an/a

-US$63m

Mar 31 2021n/an/a

-US$63m

Dec 31 2020US$1mUS$430k

-US$60m

Sep 30 2020n/an/a

-US$56m

Jun 30 2020n/an/a

-US$53m

Mar 31 2020n/an/a

-US$49m

Dec 31 2019US$517kUS$415k

-US$46m

Sep 30 2019n/an/a

-US$42m

Jun 30 2019n/an/a

-US$39m

Mar 31 2019n/an/a

-US$34m

Dec 31 2018US$606kUS$403k

-US$31m

Compensation vs Market: Manny's total compensation ($USD498.04K) is about average for companies of similar size in the US market ($USD681.28K).

Compensation vs Earnings: Manny's compensation has been consistent with company performance over the past year.

CEO

Manny Litchman (70 yo)

8.1yrs

Tenure

US$498,042

Compensation

Dr. Manuel Litchman, also known as Manny, M.D. has been the President, Chief Executive Officer and Director at Mustang Bio, Inc. since April 24, 2017 also serves as an Interim CFO since November 15, 2024 a...

Leadership Team

NamePositionTenureCompensationOwnership
Michael Weiss
Executive Chairman10yrsUS$60.00k0.0098%
$ 378.8
Manuel Litchman
President8.1yrsUS$498.04k0.049%
$ 1.9k
Peter Carney
Controller & Interim Chief Accounting Officer1.4yrsno data0.0015%
$ 58.1
Greg Furrow
Chief Quality Officer2.3yrsno datano data
Robyn Hunter
Corporate Secretaryno datano datano data

5.2yrs

Average Tenure

60yo

Average Age

Experienced Management: MBIO's management team is seasoned and experienced (5.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Michael Weiss
Executive Chairman10yrsUS$60.00k0.0098%
$ 378.8
Manuel Litchman
President8.1yrsUS$498.04k0.049%
$ 1.9k
Lindsay Rosenwald
Non-Executive Director10.2yrsUS$50.00k0.010%
$ 398.4
Michael Zelefsky
Independent Director7.9yrsUS$50.00k0.011%
$ 441.6
Neil Herskowitz
Independent & Non-Executive Director9.8yrsUS$50.00k0.012%
$ 456.6
Adam Chill
Independent Director7.9yrsUS$60.00k0.011%
$ 441.6
David Jin
Directorless than a yearUS$12.50k0.0012%
$ 45.4

8.1yrs

Average Tenure

64yo

Average Age

Experienced Board: MBIO's board of directors are considered experienced (8.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/12 09:04
End of Day Share Price 2025/05/09 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mustang Bio, Inc. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mayank MamtaniB. Riley Securities, Inc.
Justin ZelinB. Riley Securities, Inc.
Jonathan AschoffB. Riley Wealth